Insertion of Li into graphite changes the color of graphite by altering the visible light absorption; hence, we designed an optical electrochemical analog half-cell to enable direct real-time observations of the color change occurring during lithiation and delithiation.
It's deserted enough that Davidson, the more analog-minded half of the pair, can do her jogging through the hallways and staircases without seeing another soul.
When Time Warner Cable, which has been losing TV subscribers to competitors for years, reported a net loss of 128,000 in the quarter that ended Sept. 30, it noted that fully half were analog subscribers, who generally pay less and get fewer channels than digital subscribers.
Dehydrozingerone (DZG) also known as feruloylmethane, is one such recognized degradant which is a half structural analog of curcumin.
The utility of various measures of malingering was evaluated using an analog design in which half the participants (composed of three groups: naive healthy people, professionals working with head-injured people, individuals who suffered a head injury but not currently in litigation) were asked to try their best and the remainder was asked to feign believable injury.
Two forms of the arginine vasopressin (AVP) hormone are used in clinical practice: exogenous AVP and terlipressin, a synthetic analog with a longer half-life (6 h vs. 24 min for AVP).
Most compounds showed moderate to excellent potency, and compared to foretinib, the most promising analog 18b (c-Met half-maximal inhibitory concentration [IC50] = 1.39 nM) showed a 7.3-fold increase in activity against HT-29 cell line in vitro.
The minimum strength of interaction was established by competition studies using soluble synthetic peptide analogs, which showed half-maximal inhibition of yeast binding to CdS at ∼2 μM peptide.
In contrast, systemically administered GnRH analogs have longer half-life and cause greater exposure of the peripheral tissues [ 4, 29].
Two obvious options for GLP-1 receptor-based therapies are: (1) GLP-1 analogs with longer half-lives and full efficacy at the GLP-1 receptor (GLP-1R agonists); and (2) agents such as DPP 4 inhibitors that can increase plasma levels of endogenous GLP-1.
